Skin & Cosmetic
Copper-binding tripeptides and melanocortin receptor agonists studied for dermal remodeling, collagen synthesis, and pigmentation pathways. Includes GHK-Cu and melanocortin analogs. Investigational research tools for dermatological biochemistry β not for cosmetic application.
5 Articles on This Research Goal
Melanotan II: Ξ±-MSH Analog Pharmacology, Clinical History, and Safety Profile
Melanotan II is a synthetic analog of Ξ±-melanocyte-stimulating hormone investigated in early-phase clinical trials for tanning and sexual dysfunction. This review summarizes its clinical evidence and notable safety concerns.
PT-141 / Bremelanotide: Melanocortin Agonist for Hypoactive Sexual Desire Disorder β Regulatory and Clinical Evidence
PT-141, developed as bremelanotide, is a melanocortin receptor agonist FDA-approved (Vyleesi) for premenopausal women with hypoactive sexual desire disorder. This review summarizes the registrational clinical evidence.
BPC-157 and Tissue Repair Signaling Pathways
Comprehensive review of BPC-157 mechanisms in tissue repair, angiogenesis, and mucosal healing.
GHK-Cu and Collagen Remodeling in Dermal Research
Comprehensive review of GHK-Cu mechanisms in collagen synthesis and dermal remodeling.
Advanced Research Compounds: Quality Standards and Evidence Frameworks
An evidence-based framework for evaluating research compound quality, purity verification, and supplier transparency.
7 Compounds Studied Under This Goal
GHK-Cu
Skin & CosmeticA copper-binding tripeptide studied for collagen synthesis, gene expression modulation, and tissue remodeling.
Read profile βPT-141
Skin & CosmeticFDA-approved Bremelanotide (Vyleesi 2019) β acts via central nervous system melanocortin pathways.
Read profile βMelanotan II
Skin & CosmeticA cyclic Ξ±-MSH analog activating MC1R, MC3R, MC4R. Key research tool in melanocortin pharmacology.
Read profile βSpironolactone
MedicineAldosterone receptor antagonist with antiandrogenic properties
Read profile βDutasteride
MedicineDual 5-alpha reductase inhibitor (types I and II)
Read profile βFinasteride
MedicineType II 5-alpha reductase inhibitor; reduces DHT conversion
Read profile βThe Glow Blend
Blend StackGHK-Cu focused blend for collagen synthesis and tissue remodeling research.
Read profile βAll compounds, protocols, and content are for research use only (RUO). This knowledge graph documents biochemical research pathways and is not a treatment guide. For laboratory and research purposes only.